NCT06155136View on ClinicalTrials.gov

RWE on Patients With mPDAC Long-term Survival After Treatment With Liposomal Irinotecan

Active, not recruitingOBSERVATIONAL
Enrollment

163

Participants

Timeline

Start Date

October 6, 2023

Primary Completion Date

March 30, 2024

Study Completion Date

September 30, 2024

Conditions
Pancreatic Cancer Metastatic
Trial Locations (1)

81377

Klinikum der Universität München, - Anstalt des öffentlichen Rechts -, Munich

All Listed Sponsors
lead

Servier Affaires Médicales

INDUSTRY

NCT06155136 - RWE on Patients With mPDAC Long-term Survival After Treatment With Liposomal Irinotecan | Biotech Hunter | Biotech Hunter